loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Sun Pharmaceutical Industries said it will acquire 100% of Mumbai-based Innovcare Lifesciences

ICICIdirect Research 22 Jun 2026 DISCLAIMER

News: Sun Pharmaceutical Industries said it will acquire 100% of Mumbai-based Innovcare Lifesciences for about ₹271.2 crore through a cash transaction. Innovcare is engaged in the marketing and distribution of pharmaceutical, nutraceutical and cosmeceutical products and reported revenue of ₹94.1 crore in FY26. The transaction is expected to be completed on or before July 31, 2026, and does not require any regulatory approvals.

View: Innovcare specializes in the marketing and distribution of branded nutraceutical and functional foods for lifestyle-related disorders. The transaction is valuing the target at 2.9x sales and the acquisition is aimed to strengthen Sun Pharma’s product portfolio.

Impact: Neutral

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere